Company: DVAX
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001029142-25-000117
Chunk: 209

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 209
---
(76,659)3,408 Provision for income taxes(2,495)(3,520)(719)(743)Net income (loss)$18,721 $11,386 $(77,378)$2,665 Net income (loss) per share attributable to common stockholders    Basic$0.16 $0.09 $(0.63)$0.02 Diluted$0.14 $0.08 $(0.63)$0.02 Weighted-average shares used in computing net income (loss) per share attributable to common stockholders:    Basic119,317 130,916 122,079 130,551 Diluted138,356 154,468 122,079 133,582 

See accompanying notes.

5

Table of Contents

Condensed Consolidated Statements of Comprehensive Income (loss)

(In thousands)

(Unaudited)

 Three Months Ended June 30,Six Months Ended June 30, 2025202420252024Net income (loss)$18,721 $11,386 $(77,378)$2,665 Other comprehensive income (loss), net of tax:        Change in unrealized gain or loss on marketable securities available-for-sale(443)(289)(78)(1,746)Cumulative foreign currency translation adjustments3,739 (249)5,452 (1,057)Total other comprehensive income (loss)3,296 (538)5,374 (2,803)Total comprehensive income (loss)$22,017 $10,848 $(72,004)$(138)

See accompanying notes.

6

Dynavax Technologies Corporation 

Condensed Consolidated Statements of Stockholders’ Equity 

(In thousands) 

(Unaudited) 

 Common Stock Preferred StockThree Months Ended June 30, 2025SharesPar AmountSharesPar AmountAdditionalPaid-In CapitalAccumulatedOtherComprehensive (Loss) IncomeAccumulated Deficit TotalStockholders' EquityBalances at March 31, 2025123,697$124 -$- $1,532,835 $(2,644)$(999,374)$530,941 Issuance of common stock upon exercise of stock options53---235--235Issuance of common stock upon release of restricted and performance stock awards, net of statutory tax withholdings76---(421)--(421)Repurchase of common stock inclusive of